85 related articles for article (PubMed ID: 11814478)
1. Changes in membrane microenvironment and signal transduction in platelets from NIDDM patients-a pilot study.
Srivastava K; Dash D
Clin Chim Acta; 2002 Mar; 317(1-2):213-20. PubMed ID: 11814478
[TBL] [Abstract][Full Text] [Related]
2. Altered membrane fluidity and signal transduction in the platelets from patients of thrombotic stroke.
Srivastava K; Dash D
Mol Cell Biochem; 2001 Aug; 224(1-2):143-9. PubMed ID: 11693191
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of myosin light chain in resting platelets from NIDDM patients is enhanced: correlation with spontaneous aggregation.
Fukuda K; Ozaki Y; Satoh K; Kume S; Tawata M; Onaya T; Sakurada K; Seto M; Sasaki Y
Diabetes; 1997 Mar; 46(3):488-93. PubMed ID: 9032107
[TBL] [Abstract][Full Text] [Related]
4. Sustained stimulation of platelet thrombin receptor is associated with tyrosine dephosphorylation of a novel p67 peptide in a manner regulated by extracellular calcium.
Karim ZA; Mukhopadhyay S; Ramars AS; Dash D
Biochim Biophys Acta; 2004 Aug; 1693(2):147-57. PubMed ID: 15313016
[TBL] [Abstract][Full Text] [Related]
5. Cytosolic Ca profile of resting and thrombin-stimulated platelets from black women with NIDDM.
Zentay Z; Raguwanshi M; Reddi A; Lasker N; Dasmahapatra A; Aviv A
J Diabetes Complications; 1995; 9(2):74-80. PubMed ID: 7599351
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine unphosphorylated platelet SHP-1 is a substrate for calpain.
Falet H; Pain S; Rendu F
Biochem Biophys Res Commun; 1998 Nov; 252(1):51-5. PubMed ID: 9813145
[TBL] [Abstract][Full Text] [Related]
7. Modified fluidity and lipid composition in lipoproteins and platelet membranes from diabetic patients.
Rabini RA; Ferretti G; Galassi R; Taus M; Curatola G; Tangorra A; Fumelli P; Mazzanti L
Clin Biochem; 1994 Oct; 27(5):381-5. PubMed ID: 7867216
[TBL] [Abstract][Full Text] [Related]
8. Platelet sarcoplasmic endoplasmic reticulum Ca2+-ATPase and mu-calpain activity are altered in type 2 diabetes mellitus and restored by rosiglitazone.
Randriamboavonjy V; Pistrosch F; Bölck B; Schwinger RH; Dixit M; Badenhoop K; Cohen RA; Busse R; Fleming I
Circulation; 2008 Jan; 117(1):52-60. PubMed ID: 18071073
[TBL] [Abstract][Full Text] [Related]
9. Thrombin-induced platelet aggregation involves an indirect proteolytic cleavage of aggregin by calpain.
Puri RN; Zhou FX; Bradford H; Hu CJ; Colman RF; Colman RW
Arch Biochem Biophys; 1989 Jun; 271(2):346-58. PubMed ID: 2543293
[TBL] [Abstract][Full Text] [Related]
10. Changes in phosphoinositide turnover, Ca2+ mobilization, and protein phosphorylation in platelets from NIDDM patients.
Ishii H; Umeda F; Hashimoto T; Nawata H
Diabetes; 1990 Dec; 39(12):1561-8. PubMed ID: 2174010
[TBL] [Abstract][Full Text] [Related]
11. Platelets from eclampsia patients have reduced membrane microviscosity and lower activities of the signalling enzymes.
Koner BC; Jain M; Dash D
Int J Biochem Cell Biol; 1998 Jan; 30(1):147-54. PubMed ID: 9597760
[TBL] [Abstract][Full Text] [Related]
12. Disruption of the mouse mu-calpain gene reveals an essential role in platelet function.
Azam M; Andrabi SS; Sahr KE; Kamath L; Kuliopulos A; Chishti AH
Mol Cell Biol; 2001 Mar; 21(6):2213-20. PubMed ID: 11238954
[TBL] [Abstract][Full Text] [Related]
13. Involvement of proline-rich tyrosine kinase 2 in platelet activation: tyrosine phosphorylation mostly dependent on alphaIIbbeta3 integrin and protein kinase C, translocation to the cytoskeleton and association with Shc through Grb2.
Ohmori T; Yatomi Y; Asazuma N; Satoh K; Ozaki Y
Biochem J; 2000 Apr; 347(Pt 2):561-9. PubMed ID: 10749687
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine dephosphorylation, but not phosphorylation, of p130Cas is dependent on integrin alpha IIb beta 3-mediated aggregation in platelets: implication of p130Cas involvement in pathways unrelated to cytoskeletal reorganization.
Ohmori T; Yatomi Y; Inoue K; Satoh K; Ozaki Y
Biochemistry; 2000 May; 39(19):5797-807. PubMed ID: 10801330
[TBL] [Abstract][Full Text] [Related]
15. Modulation of thrombin-induced platelet aggregation by inhibition of calpain by a synthetic peptide derived from the thiol-protease inhibitory sequence of kininogens and S-(3-nitro-2-pyridinesulfenyl)-cysteine.
Puri RN; Matsueda R; Umeyama H; Bradford HN; Colman RW
Eur J Biochem; 1993 May; 214(1):233-41. PubMed ID: 8389701
[TBL] [Abstract][Full Text] [Related]
16. Altered platelet functions in non-insulin-dependent diabetes mellitus (NIDDM).
Srivastava S; Joshi CS; Sethi PP; Agrawal AK; Srivastava SK; Seth PK
Thromb Res; 1994 Dec; 76(5):451-61. PubMed ID: 7900093
[TBL] [Abstract][Full Text] [Related]
17. Bruton's tyrosine kinase is a substrate of calpain in human platelets.
Mukhopadhyay S; Ramars AS; Ochs HD; Dash D
FEBS Lett; 2001 Sep; 505(1):37-41. PubMed ID: 11557038
[TBL] [Abstract][Full Text] [Related]
18. Dicer cleavage by calpain determines platelet microRNA levels and function in diabetes.
Elgheznawy A; Shi L; Hu J; Wittig I; Laban H; Pircher J; Mann A; Provost P; Randriamboavonjy V; Fleming I
Circ Res; 2015 Jul; 117(2):157-65. PubMed ID: 25944670
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine-kinase activity in rabbit platelets stimulated with platelet-activating factor. The effect of inhibiting tyrosine kinase with genistein on platelet-signal-molecule elevation and functional responses.
Murphy CT; Kellie S; Westwick J
Eur J Biochem; 1993 Sep; 216(2):639-51. PubMed ID: 7690703
[TBL] [Abstract][Full Text] [Related]
20. Endogenously generated reactive oxygen species reduce PMCA activity in platelets from patients with non-insulin-dependent diabetes mellitus.
Jardín I; Redondo PC; Salido GM; Pariente JA; Rosado JA
Platelets; 2006 Aug; 17(5):283-8. PubMed ID: 16928598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
